Table 3.
Pathological laboratory values before and after LP-irinotecan TACE treatments
| CTCAE 4.03. grade | Grade 1 | Grade 2 | Grade 3 | Grade 4 |
|---|---|---|---|---|
| Max 7 days before first LP-irinotecan TACE treatment | ||||
| Serum creatinine increased | 2 | 0 | 0 | 2 |
| Bilirubin increased | 5 | 2 | 0 | 0 |
| SGPT increased | 12 | 2 | 0 | 0 |
| SGOT increased | 15 | 1 | 0 | 0 |
| Albumin decreased | 0 | 1 | 0 | 0 |
| LDH increased | 20 | N/A | N/A | N/A |
| Alkaline phosphatase increased | 20 | 4 | 2 | 0 |
| Neutrophils decreased | 1 | 0 | 0 | 1 |
| Platelets decreased | 8 | 0 | 0 | 0 |
| Lymphocytes decreased | 7 | 4 | 1 | 1 |
| 1–9 days before consecutive treatments | ||||
| Serum creatinine increased | 4 | 0 | 0 | 0 |
| Bilirubin increased | 6 | 3 | 0 | 0 |
| SGPT increased | 26 | 5 | 1 | 0 |
| SGOT increased | 28 | 2 | 0 | 0 |
| Albumin decreased | 0 | 3 | 0 | 0 |
| LDH increased | 27 | N/A | N/A | N/A |
| Alkaline phosphatase increased | 44 | 10 | 5 | 0 |
| Neutrophils decreased | 2 | 0 | 0 | 1 |
| Platelets decreased | 5 | 0 | 0 | 0 |
| Lymphocytes decreased | 21 | 5 | 2 | 2 |
One session from one patient was removed because the date of blood sampling was out of time range (48 days)